Nephros (NEPH) Income from Non-Controlling Interests (2013 - 2022)
Nephros (NEPH) posted quarterly Income from Non-Controlling Interests of $70000.0 for Q4 2022, up 14.75% year-over-year from $61000.0 in Q4 2021, and down 9.09% quarter-over-quarter from $77000.0 in Q3 2022.
Nephros (NEPH) Income from Non-Controlling Interests (2013 - 2022) Analysis & Trends
Nephros' Income from Non-Controlling Interests history runs 7 years deep, the most recent figure standing at $70000.0 for Q4 2022.
- In Q4 2022, Income from Non-Controlling Interests rose 14.75% year-over-year to $70000.0; the TTM figure through Dec 2022 stood at $276000.0 (up 15.0% YoY), while the FY2022 annual figure was $276000.0, up 15.0% from the prior year.
- Income from Non-Controlling Interests for Q4 2022 stood at $70000.0, down from $77000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $421000.0 in Q4 2019, with the low at -$93000.0 in Q4 2018.
- The 5-year median for Income from Non-Controlling Interests is $60000.0 (2020), against an average of $51111.1.
- Peak annual rise in Income from Non-Controlling Interests reached 552.69% in 2019, while the deepest fall reached 475.0% in 2019.
- Nephros' Income from Non-Controlling Interests stood at -$93000.0 in 2018, then jumped by 552.69% to $421000.0 in 2019, then sank by 85.51% to $61000.0 in 2020, then changed by 0.0% to $61000.0 in 2021, then rose by 14.75% to $70000.0 in 2022.
- Business Quant data shows NEPH's Income from Non-Controlling Interests at $70000.0 in Q4 2022, $77000.0 in Q3 2022, and $66000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 79.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 77,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Mar 31, 2022 | 63,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Sep 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 60,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 61,000.00 |
| Sep 30, 2020 | 60,000.00 |
| Jun 30, 2020 | 60,000.00 |
| Mar 31, 2020 | 59,000.00 |
| Dec 31, 2019 | 421,000.00 |
| Sep 30, 2019 | -60,000.00 |
| Jun 30, 2019 | -61,000.00 |
| Mar 31, 2019 | -59,000.00 |
| Dec 31, 2018 | -93,000.00 |
| Sep 30, 2018 | 16,000.00 |
| Sep 30, 2014 | -3.43 Mn |
| Jun 30, 2013 | 607,000.00 |